BackSILO Pharma Overview

SILO Pharma Receivables

Latest receivables for SILO: $0.

Get informed when a big investor buys or sells

+ Follow
Receivables
$0.00

Peer trimmed avg / median

Loading

SILO Pharma Receivables History

Loading

SILO Pharma vs. peers: Receivables Comparison

Loading

SILO Pharma Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

SILO Pharma (SILO) FAQ

As of the most recent data (September 2026), SILO shows a receivables of $0. In the prior-year period, the figure was $0. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, SILO's receivables is now $0 (was $0). Pairing that YoY change with peer averages gives a clearer picture of whether SILO Pharma is outperforming or lagging.

Tracking SILO's receivables over time shows whether SILO Pharma is scaling, shrinking, or reshaping that part of the business. The current reading is $0 In the prior-year period, the figure was $0. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this receivables page, Stockcircle has SILO Pharma's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect receivables (currently $0) with ownership activity and broader fundamentals.

SILO Pharma's receivables is $0; compare it with other Finance names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.